Form D · Biotechnology
ONDINE BIOPHARMA Corp
Vancouver, A1 · CIK 0001286774
Offering snapshot reported Apr 7, 2010 · SEC filing
- Reported sold
- $45.5K Offering amount: $45.5K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 5, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 7, 2010 | Initial | $45,463 | No comparison | 3 | SEC filing |
| Dec 29, 2009 | Initial | $239,308 | No comparison | 2 | SEC filing |
| Dec 21, 2009 | Initial | $480,183 | No comparison | 4 | SEC filing |
| Sep 11, 2009 | Initial | $43,360 | No comparison | 1 | SEC filing |
| Feb 10, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-64540
Amount is US$ value of 760,0000 units issued at C$0.06 each, each unit consists of one common share and one warrant to purchase one common share for C$0.075 until Apr 5/11. Bank of CAD daily noon ex. rate is 1CAD=0.9970 US dollars on Apr 7, 10.
private sale of units see also Item 13 for more information.
Source: Form D, filed Apr 7, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Merrill Biel | Director |
| Michael Crane | Director |
| Carolyn Cross | Director, Executive |
| Thomas Dawson | Executive |
| William Harper | Executive |
| Terence Holland | Director |
| Nicholas Loebel | Executive |
| Nicolas Loebel | Executive |
| Margaret Shaw | Director |
| Colin Watt | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
910 1100 Melville St
Vancouver, A1, V6E4A6
Vancouver, A1, V6E4A6